Three-dimensional quantitative structure-activity relationship of interleukin 1-β converting enzyme inhibitors: A comparative molecular field analysis study

Journal of Medicinal Chemistry

Volumn 42, Issue 3, 1999, Pages 373-380

  Kulkarni, Santosh S ^a   Kulkarni, Vithal M ^a  

^a UNIVERSITY OF MUMBAI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; MOLECULAR INTERACTION; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STEREOCHEMISTRY; THREE DIMENSIONAL IMAGING;

CASPASE 1; CRYSTALLOGRAPHY, X-RAY; CYSTEINE PROTEINASE INHIBITORS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032972812     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9708442     Document Type: Article

References (44)

1. Kostura, M. J.; Tocci, M. J.; Limjuco, G.; Chin, J.; Cameron, P.; Hillman, A. G.; Chartrain, N. A.; Schmidt, J. A. Indentification of a Monocyte Specific Pre-interleukin 1β Convertase Activity. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5227-5231.
2. Black, R. A.; Kronheim, S. R.; Sleath, P. R. Activation of Interleukin-1β by a Co-induced Protease. FEBS Lett. 1989, 247, 386-390.
3. Thornberry, N. A.; Bull, H. G.; Calaycay, J. R.; Chapman, K. T.; Howard, A. D.; Kostura, M. J.; Miller, D. K.; Molineaux, S. M.; Weidner, J. R.; Aunins, J.; Elliston, K. O.; Ayala, J. A.; Casano, F. J.; Chin, J.; Ding, G. J.-F.; Egger, L. A.; Gaffney, E. P.; Limjuco, G.; Palyha, O. C.; Raju, S. M.; Rolando, A. M.; Salley, J. P.; Yamin, T. T.; Lee, T. D.; Shively, J. E.; MacCross, M.; Mumford, R. A.; Schmidt, J. A.; Tocci, M. J. A Novel Heterodimeric Cysteine Protease is Required for Interleukin-1/β Processing in Monocytes. Nature 1992, 356, 768-774.
4. Howard, A. D.; Kostura, M. J.; Thornberry, N.; Ding, G. J. F.; Limjuco, G.; Weidner, J.; Salley, J. P.; Hogquist, K. A.; Chaplin, D. D.; Mumford, R. A.; Schmidt, J. A.; Tocci, M. J. IL-1-Converting Enzyme Requires Aspartic Acid Residues for Processing of the IL-1β Precursor at Two Distinct Sites and Does Not Cleave 31-kDa IL-1α. J. Immunol. 1991, 147, 2964-2969.
5. Dinarello, C. A.; Wolff, S. M. The Role of Interleukin-1 in Disease. N. Engl. J. Med. 1993, 328, 106-113.
6. Hogquist, K. A.; Nett, M. A.; Unanue, E. R.; Chaplin, D. D. Interleukin 1 is Processed and Released During Apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8485-8469.
7. Miura, M.; Zhu, H.; Rotello, R.; Hartwieg, E. A.; Yuan, J. Induction of Apoptosis in Fibroblasts by IL-1β-Converting Enzyme, A Mammalian Homologue of the C. elegans Cell Death Gene ced-3. Cell 1993, 75, 653-660.
8. Barr, P. J.; Tomei, L. D. Apoptosis and its Role in Human Disease. Biotechnology 1994, 12, 487-493.
9. Sleath, P. R.; Hendrickson, R. C.; Kronheim, S. R.; March, C. J.; Black, R. A. Substrate Specificity of the Protease That Processes Human Interleukin-1β. J. Biol. Chem. 1990, 265, 14526-14528.
10. Chapman, K. T. Synthesis of a Potent, Reversible Inhibitor of Interleukin-1/β Converting Enzyme. Biorg. Med. Chem. Lett. 1992, 2, 613-618.
11. Graybill, T. L.; Dolle, R. E.; Helaszek, C. T.; Miller, R. E.; Ator, M. A. Preparation and Evaluation of Peptidic Aspartyl Hemiacetals as Reversible Inhibitors of Interleukin-1β Converting Enzyme (ICE). Int. J. Peptide Protein Res. 1994, 44, 173-182.
12. Krantz, A.; Copp, L. J.; Coles, P. J.; Smith, R. A.; Heard, S. B. Peptidyl (Acyloxy)methyl Ketones and the Quiescent Affinity Label Concept: The Departing Group as a Variable Structural Element in the Design of Inactivators of Cysteine Proteinases. Biochemistry 1991, 30, 4678-4687.
13. Thornberry, N. A.; Peterson, E. P.; Zhao, J. J.; Howard, A. D.; Griffin, P. R.; Chapman, K. T. Inactivation of Interleukin-1β Converting Enzyme by Peptide (Acyloxy)methyl Ketones. Biochemistry 1994, 33, 3934-3940.
14. Dolle, R. E.; Hoyer, D.; Prasad, C. V. C.; Schmidt, S. J.; Helaszek, C. T.; Miller, R. E.; Ator, M. A. P1 Aspartate-Based Peptide α-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1β-Converting Enzyme. J. Med. Chem, 1994, 37, 563-564.
15. 3 Amido Nitrogens for Enzyme-Peptide Inhibitor Binding. J. Med. Chem. 1994, 37, 3863-3866.
16. Dolle, R. E.; Singh, J.; Whipple, D.; Osifo, I. K.; Speier, G.; Graybill, T. L.; Gregory, J. S.; Harris, A. L.; Helaszek, C. T.; Miller, R. E.; Ator, M. A. Aspartyl α-((Diphenyl-phosphinyl)oxy)-methyl Ketones as Novel Inhibitors of Interleukin-1β Converting Enzyme. Utility of the Diphenylphosphinic Acid Leaving Group for the Inhibition of Cysteine Proteases. J. Med. Chem. 1995, 38, 220-222.
17. Cramer, R. D., III.; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
18. Clark, M.; Cramer, R. D., III; Jones, D. M.; Patterson, D. E.; Simeroth, P. E. Comparative Molecular Field Analysis (CoMFA) 2. Toward its use with 3-D structural Databases. Tetrahedron Comput. Method 1990, 3, 47-59.
19. Wold, S.; Ruhe, A.; Wold, H.; Dunn, W. J. The Covariance Problem In Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses. SIAM J. Sci. Stat. Comput. 1984, 5, 735-743.
20. Cramer, R. D., III, Bunce, J. D.; Patterson, D. E. Crossvalidation, Bootstrapping and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies. Quant. Struct.-Act. Relat. 1988, 7, 18-25.
21. Loughney, D. A.; Schwender, C. F. A Comparison of Progestin and Androgen Receptor Binding using the CoMFA Technique. J. Comput.-Aided Mol. Des. 1992, 6, 569-581.
22. Bjorkroth, J. P.; Pakkanen, T. A.; Lindroos, J.; Pohjala, E.; Hanhijarvi, H.; Lauren, L.; Hannuniemi, R.; Juhakoski, A.; Kippo, K.; Kleimola, T. Comparative Molecular Field Analysis of Some Clodronic Acid Esters. J. Med. Chem. 1991, 34, 2338-2343.
23. Raghavan, K.; Buolamwini, J. K.; Fesen, M. R.; Pommier, Y.; Kohn, K. W.; Weinstein, J. N. Three-Dimensional Quantitative Structure-Activity Relationship (QSAR) of HIV Integrase Inhibitors: A Comparative Molecular Field Analysis (CoMFA) Study. J. Med. Chem. 1995, 38, 890-897.
24. DePriest, S. A.; Mayer, D.; Naylor, C. B.; Marshall, G. R. 3D-QSAR of Angiotensin-Converting Enzyme and Thermolysin Inhibitors: A Comparison of CoMFA Models Based on Deduced and Experimentally Determined Active Site Geometries. J. Am. Chem. Soc. 1993, 113, 5372-5384.
25. Waller, C. L.; Marshall, G. R. Three-Dimensional Quantitative Structure-Activity Relatioship of Angiotensin-Converting Enzyme and Thermolysin Inhibitors. II. A Comparison of CoMFA Models Incorporating Molecular Orbital Fields and Desolvation Free Energies Based on Active-Analogue and Complementary-Receptor-Field Alignment Rules. J. Med. Chem. 1993, 36, 2390-2403.
26. Horwitz, J. P.; Massova, I.; Wiese, T. E.; Wozniak, A. J.; Corbett, T. H.; Sebolt-Leopold, J. S.; Capps, D. B.; Leopold, W. R. Comparative Molecular Field Analysis of in Vitro Growth Inhibition of L1210 and HCT-8 Cells by Some Pyrazoloacridines. J. Med. Chem. 1993, 36, 3511-3516.
27. Waller, C. L.; McKinney, J. D. Comparative Molecular Field Analysis of Polyhalogenated Dibenzo-p-dioxins, Dibenzofurans, and Biphenyls. J. Med. Chem. 1992, 35, 3660-3666.
28. Tong, W.; Collantes, E. R.; Chen, Y.; Welsh, W. J. A Comparative Molecular Field Analysis Study of N-Benzylpiperidines as Acetylcholinesterase Inhibitors. J. Med. Chem. 1996, 39, 380-387.
29. Cho, S. J.; Garsia, M. L. S.; Bier, J.; Tropsha, A. Structure-Based Alignment and Comparative Molecular Field Analysis of Acetylcholinesterase Inhibitors. J. Med. Chem. 1996, 39, 5064-5071.
30. Waller, C. L.; Oprea, T. I.; Giolitti, A.; Marshall, G. R. Three-Dimensional QSAR of Human Immunodeficiency Virus (I) Protease Inhibitors. 1. A CoMFA Study Employing Experimentally-Determined Alignment Rules. J. Med. Chem. 1993, 36, 4152-4160.
31. Diana, G. D.; Kowalczyk, P.; Treasurywala, A. M.; Oglesby, R. C.; Pevear, D. C.; Dutko, F. J. CoMFA Analysis of the Interactions of Antipicornavirus Compounds in the Binding Pocket of Human Rhinovirus-14. J. Med. Chem. 1992, 35, 1002-1008.
32. Klebe, G.; Abraham, U. On the Prediction of Binding Properties of Drug Molecules by Comparative Molecular Field Analysis. J. Med. Chem. 1993, 36, 70-80.
33. Nicklaus, M. C.; Milne, G. W. A.; Burke, T. R. Jr. QSAR of Conformationally Flexible Molecules. Comparative Molecular Field Analysis of Protein-Tyrosine Kinase Inhibitors. J. Comput.-Aided Mol. Des. 1992, 6, 487-504.
34. Wilson, K. P.; Black, J. A.; Thomson, J. A.; Kim, E. E.; Griffith, J. P.; Navia, M. A.; Murcko, M. A.; Chambers, S. P.; Aldape, R. A.; Raybuck, S. A.; Livingston, D. J. Structure and Mechanism of Interleukin-1β Converting Enzyme. Nature 1994, 370, 270-275.
35. Dolle, R. E.; Prouty, C. P.; Prasad, C. V. C.; Cook, E.; Saha, A.; Ross, T. M.; Salvino, J. M.; Helaszek, C. T.; Ator, M. A. First Examples of Peptidomimetic Inhibitors of Interleukin-1β Converting Enzyme. J. Med. Chem. 1996, 39, 2438-2440.
36. SYBYL 6.22 molecular modelling software is available from Tripos Associates Inc., 1699 S. Hanley Road, St. Louis, MO 63144-2913.
37. Clark, M.; Cramer, R. D., III; Van Opdenbosh, N. Validation of the General Purpose Tripos 5.2 Force Field. J. Comput. Chem. 1989, 10, 982-1012.
38. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. AM1 A New General Purpose Quantum Mechanical Molecular Model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
39. The program MOPAC 6.0 is available from Quantum Chemistry Program Exchange, no. 455.
40. Hariprasad, V.; Kulkarni, V. M.; Docking of a Series of Peptide-Based Interleukin-1β Converting Enzyme Inhibitors with Aspartyl Hemiacetals, α-((2,6-Dichlorobenzoyl)oxy)methyl and (Acyloxy)methyl Ketone Moieties. J. Mol. Model. 1997, 3, 443-454.
41. 2 Homodimer. Cell 1994, 78, 343-352.
42. SYBYL 6.2 Theory Manual; Tripos Associates: St. Louis, MO, July 1995; p 56.
43. 3 Peptidomimetic Class of Interleukin - 1β-Converting Enzyme Inhibitor. J. Med. Chem. 1997, 40, 1941-1946.
44. ClogP, version 1.0.0; Biobyte Corp., 201 West, 4th St., Suite 204, Claremont, CA 91711.